HomeCompareMMIRF vs PG

MMIRF vs PG: Dividend Comparison 2026

MMIRF yields 4444.44% · PG yields 2.93%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MMIRF wins by $19857738408180.43M in total portfolio value
10 years
MMIRF
MMIRF
● Live price
4444.44%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19857738408180.48M
Annual income
$19,016,069,933,146,186,000.00
Full MMIRF calculator →
PG
Procter & Gamble
● Live price
2.93%
Share price
$144.42
Annual div
$4.23
5Y div CAGR
31.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.5K
Annual income
$9,992.83
Full PG calculator →

Portfolio growth — MMIRF vs PG

📍 MMIRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMMIRFPG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MMIRF + PG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MMIRF pays
PG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MMIRF
Annual income on $10K today (after 15% tax)
$377,777.78/yr
After 10yr DRIP, annual income (after tax)
$16,163,659,443,174,257,000.00/yr
PG
Annual income on $10K today (after 15% tax)
$248.80/yr
After 10yr DRIP, annual income (after tax)
$8,493.91/yr
At 15% tax rate, MMIRF beats the other by $16,163,659,443,174,248,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MMIRF + PG for your $10,000?

MMIRF: 50%PG: 50%
100% PG50/50100% MMIRF
Portfolio after 10yr
$9928869204090.27M
Annual income
$9,508,034,966,573,097,000.00/yr
Blended yield
95.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PG right now

MMIRF
No analyst data
Altman Z
-50.9
Piotroski
2/9
PG
Analyst Ratings
29
Buy
22
Hold
1
Sell
Consensus: Buy
Price Target
$167.67
+16.1% upside vs current
Range: $150.00 — $179.00
Altman Z
5.3
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MMIRF buys
0
PG buys
0
No recent congressional trades found for MMIRF or PG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMMIRFPG
Forward yield4444.44%2.93%
Annual dividend / share$2.00$4.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%31.1%
Portfolio after 10y$19857738408180.48M$51.5K
Annual income after 10y$19,016,069,933,146,186,000.00$9,992.83
Total dividends collected$19800558376185.16M$29.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: MMIRF vs PG ($10,000, DRIP)

YearMMIRF PortfolioMMIRF Income/yrPG PortfolioPG Income/yrGap
1← crossover$455,144$444,444.44$11,004$383.73+$444.1KMMIRF
2$19,392,277$18,905,272.87$12,207$521.25+$19.38MMMIRF
3$773,548,232$752,798,494.96$13,678$713.84+$773.53MMMIRF
4$28,891,953,466$28,064,256,857.57$15,513$987.38+$28891.94MMMIRF
5$1,010,538,077,568$979,623,687,360.21$17,858$1,382.44+$1010538.06MMMIRF
6$33,103,483,882,921$32,022,208,139,922.89$20,929$1,964.45+$33103483.86MMMIRF
7$1,015,787,352,937,823$980,366,625,183,097.90$25,069$2,842.17+$1015787352.91MMMIRF
8$29,201,617,438,828,424$28,114,724,971,184,950.00$30,826$4,202.54+$29201617438.80MMMIRF
9$786,606,051,433,916,900$755,360,320,774,370,600.00$39,116$6,379.22+$786606051433.88MMMIRF
10$19,857,738,408,180,478,000$19,016,069,933,146,186,000.00$51,534$9,992.83+$19857738408180.43MMMIRF

MMIRF vs PG: Complete Analysis 2026

MMIRFStock

MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, the Asia Pacific, and internationally. The company offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product to perform preliminary screening of HIV and hepatitis. It also provides Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics; and Reveal HP, a rapid H. Pylori antibody test, which detects helicobacter pylori (HP) antibodies in serum, plasma, or whole blood produced in response to HP infection. In addition, the company offers VYRA CoV2 that detects antigens specific for the nucleocapsid region of SARS-CoV-2; VYRA CoV2Flu, a combination viral nucleocapsid antigen tests that detects infection caused by SARS-CoV-2, and Influenza A and Influenza B; and REVEALCOVID-19, an antibody test. It sells its products through a network of medical distributors and strategic business development partners to customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care clinics, governments, aid organizations, and public health agencies. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.

Full MMIRF Calculator →

PGConsumer Staples

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.

Full PG Calculator →
📬

Get this MMIRF vs PG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MMIRF vs SCHDMMIRF vs JEPIMMIRF vs OMMIRF vs KOMMIRF vs MAINMMIRF vs KMBMMIRF vs CLMMIRF vs CHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.